Downregulation of TCF signaling by dominant negative TCF4 (dnTCF4) led to reduced expression of TCF targets, including c-Myc, BMP-4, Axin-2, and Lef-1, in all three tumors, as well as inhibition of tumor cell proliferation in AGS. This evidence concerns the gene MYC and neoplasm.